A virtual accelerator listing for early-stage healthcare companies, with support in business-model validation, commercialization planning, and funding preparation.
Some program details are not available yet. Check current requirements, deadlines, and terms before you apply. Official program page
XLerateHealth Louisville is the Louisville-specific listing for XLerateHealth’s healthcare accelerator; Gust lists Louisville and Flint as separate locations. The 2024–2025 Gust entry describes the program as virtual and targets early-stage healthcare companies.
The listing names biotechnology, digital health, healthcare services, life sciences, and medical devices and equipment among its industries. It describes help testing a business model, planning commercialization, and preparing to attract funding. These are described forms of support, not a promise of investment.
Gust’s 2024–2025 entry lists capacity for six companies and an equity stake of up to 2%. Those are terms advertised for that listing, not confirmation of actual enrollment or current signed participant terms.
The 2024–2025 Gust listing targets early-stage healthcare companies. It does not establish additional founder, geographic, incorporation, or product-readiness requirements.
The 2024–2025 listing describes assistance with business-model validation, commercialization planning, and preparation to attract funding. It does not specify a guaranteed investment.
Who can apply, how people get in and whether it is open right now.
Programs pick people whose work they can already point to. Put yours where it can be found.
The program has not published how to apply. Terms and dates change. Check the official page before you act.
Gust’s 2024–2025 listing states an equity stake of up to 2%. This is a listed maximum for that edition, not confirmation of current or signed participant terms.
It targets early-stage healthcare companies and names biotechnology, digital health, healthcare services, life sciences, and medical devices and equipment among its industries.
It describes help testing a business model, planning commercialization, and preparing to attract funding; it does not promise an investment.
The 2024–2025 Gust entry lists an equity stake of up to 2%. That is a listed maximum for the entry, not confirmation of current or signed participant terms.
The inspected Gust application listing for Louisville’s 2024–2025 edition displays enrollment as closed. That does not establish the status of the enduring program or a later intake.
Accelerator
Accelerating healthcare innovation.
From public sources
CoverMyMeds' June 2025 announcement says RxLightning joined its business.
Source: Advancing Our Mission: Expanding Medication Access Through New CapabilitiesXLerateHealth separately identifies RxLightning as a 2021 alumnus without identifying its regional track.
Source: XLerateHealth Selects 8 Healthcare Startups for 2023 Accelerator CohortMcKesson Ventures reported CoverMyMeds' acquisition of RxLightning in June 2025.
Source: CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuthXLerateHealth reported a $17.5 million Series A for RxLightning in June 2023.
Source: XLerateHealth Selects 8 Healthcare Startups for 2023 Accelerator CohortXLerateHealth's 2023 release identifies RxLightning with its 2021 alumni group.
Source: XLerateHealth Selects 8 Healthcare Startups for 2023 Accelerator CohortXLerateHealth said its scheduled 2023 Demo Day would reach investors and the healthcare and startup communities.
Source: XLerateHealth Selects 8 Healthcare Startups for 2023 Accelerator Cohort
Accelerator
AcceleratorAndreessen Horowitz
a16z crypto's in-person accelerator for early-stage web3 startups (last cohort: CSX 04, 2025).
Acceleratora16z speedrun
a16z's accelerator: up to $1M, $10M+ in credits and a 12-week in-person program in San Francisco.
AcceleratorAndreessen Horowitz
a16z's accelerator and fund for out-of-network founders, launched in 2020 (no current cohort).
Superscout Pro
Is this page right?Reviewed · How the research works